BioSpace News Archive

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that it has received clearance from the FDA for its investigational new drug application (IND) for intravenous (IV) STI-9167 (COVISHIELD) to study the safety and pharmacokinetics in healthy volunteers.

Braintale, a medtech that is deciphering white matter, spin off from the Assistance Publique-Hôpitaux de Paris, showcases, with Minoryx, a biotechnology company developing a treatment for X-linked Adrenoleukodystrophy, the results of the multicentric ADVANCE sub study with Braintale biomarker platform on the occasion of the American Academy of Neurology.

Southwest Research Institute is now home to a field emission scanning electron microscope, a powerful materials characterization tool that will aid in the research and development of a wide range of materials systems, including thin films and nanomaterials.

Growing demand for brain monitoring devices for monitoring and analyzing functions of brain, and increasing number of people suffering from neurological disorders are key factors driving market revenue growth.

Brand Institute is proud to announce working with Lipocine Inc. in developing the brand name TLANDO®, approved by the Food and Drug Administration (FDA) on March 28, 2022.

Growing demand for minimally invasive procedures and increasing incidence of respiratory disorders are some key factors driving market revenue growth of the bronchoscopy market.

Saniona, a clinical-stage biopharmaceutical company focused on rare diseases, announced that it will refocus its strategy on ion channel research and development and, as a result, further streamline its operations.

RightEye, the world’s leading eye-tracking biomarker company, has signed a research collaboration agreement with the Massachusetts Institute of Technology (MIT) to study an oculomotor “signature” for Lyme disease.

Increasing prevalence of blood cancer including leukemia, and surging demand for early diagnosis and treatment monitoring are major factors driving market revenue growth.

Increasing prevalence of chronic diseases, rising focus on improving healthcare supply chain efficiency at lower prices, and growing demand for advanced medical instruments, drugs and devices are some key factors expected to drive global market growth.